prepare your lab for a better future: how microsampling works for lab directors
by Neoteryx, on Jul 21, 2017 12:00:00 PM
Advances in bioanalytical techniques has created the potential to use smaller sample volumes for assessing drug and chemical exposure in blood, plasma, or serum. The Mitra® device opens the door for molecular research labs, animal testing facilities, and others to exceed common organization goals of running a more efficient operation, reducing costs, providing better service, and generating meaningful results. Volumetric Absorptive Microsampling (VAMS™) technology faciliates sample collection that is simple, economical, and efficient.
When implemented successfully, microsampling allows lab directors to report new findings more quickly. Users collect better data more efficiently and publish results that will change the world.
In molecular research, the CE-IVD, FDA Class I Mitra microsampling device has successfully overcome traditional DBS card deficiencies and is proven to be compatible with off-the-shelf DNA / RNA purification and isolation kits so that you can generate important results with just microliters of blood. In the realm of animal research, has been shown to generate better TK profiles and allow lab directors to combine PK/PD and/or efficacy assessments in the same animal.
Let the promise of microsampling deliver phenomenal results to both your lab and organization! Dried blood microsample collection opens up new and exciting opportunities to better serve and access populations near and far, reduce animal usage and reliance on satellite animal populations, increase productivity, and expand operations, profitably.
- Expand your tests offering and research focuses
- Suitable for low or compromised blood volume donors
- Improve adherence with microsampling ease and convenience
- Simplify sample processing workflows with dried blood
Contact us today for more information on this technological breakthrough for lab directors in animal testing, molecular research, and beyond.